In vitromodeling of host-parasite interactions: the 'subgingival' biofilm challenge of primary human epithelial cells
© Guggenheim et al; licensee BioMed Central Ltd. 2009
Received: 22 April 2009
Accepted: 31 December 2009
Published: 31 December 2009
Microbial biofilms are known to cause an increasing number of chronic inflammatory and infectious conditions. A classical example is chronic periodontal disease, a condition initiated by the subgingival dental plaque biofilm on gingival epithelial tissues. We describe here a new model that permits the examination of interactions between the bacterial biofilm and host cells in general. We use primary human gingival epithelial cells (HGEC) and an in vitro grown biofilm, comprising nine frequently studied and representative subgingival plaque bacteria.
We describe the growth of a mature 'subgingival' in vitro biofilm, its composition during development, its ability to adapt to aerobic conditions and how we expose in vitro a HGEC monolayer to this biofilm. Challenging the host derived HGEC with the biofilm invoked apoptosis in the epithelial cells, triggered release of pro-inflammatory cytokines and in parallel induced rapid degradation of the cytokines by biofilm-generated enzymes.
We developed an experimental in vitro model to study processes taking place in the gingival crevice during the initiation of inflammation. The new model takes into account that the microbial challenge derives from a biofilm community and not from planktonically cultured bacterial strains. It will facilitate easily the introduction of additional host cells such as neutrophils for future biofilm:host cell challenge studies. Our methodology may generate particular interest, as it should be widely applicable to other biofilm-related chronic inflammatory diseases.
In most natural environments bacteria exist as highly structured dense surface attached aggregates designated as biofilms [1, 2]. This applies also to bacteria colonizing the skin and human mucosa. Under certain conditions, biofilms may cause disease. Classical examples are gingivitis and chronic inflammatory periodontal disease. Dental plaque colonizing teeth initiates inflammation in the adjacent host gingival epithelium. The epithelial cells lining the crevice between the gum and the tooth are the first line of defense to the plaque bacteria . Dental plaque has long been recognized as a complex polymicrobial biofilm [1, 4–6]. The maturation of this biofilm involves a change in the microbiota from predominantly Gram-positive facultative anaerobes to Gram-negative anaerobic bacteria . As the plaque accumulates, it induces inflammation in the adjacent host tissues and the biofilm over time extends under the gum, down the root surface, creating a niche favoring the growth of fastidious anaerobes, such as Spirochaetes and Bacteriodetes .
Until very recently, in vitro experiments to elucidate this host-parasite relationship, utilized human cell line cultures challenged with putative pathogenic periodontal bacteria that were invariably used in the planktonic state, that is as cell suspensions in growth media or buffered solutions. Evidence from such experiments is far disconnected from in vivo conditions and although useful as a first approach, they poorly reflect the challenge to host cells by multi-species biofilms. Biofilms are comprised of either mono-species or multi-species biocenoses , and their eradication is more difficult than for planktonic bacteria as they are highly resistant to antimicrobial agents and the host's immune response . Pathogenic biofilms are often associated with chronic inflammatory diseases such as periodontitis, or chronic conditions that are difficult to treat such as the colonization of urinary catheters and endotracheal tubings [2, 10–14]. Biofilm or co-culture studies composed of one to three bacteria have been reported in the past [15–17]; however, with hundreds of different bacteria present in the human mouth, a more extensive biofilm study model will better elucidate the cellular responses triggered by bacteria that usually colonize with other bacteria in vivo.
We developed an in vitro biofilm model mimicking subgingival plaque to challenge cultured primary gingival epithelial cells (HGEC) in order to assess interactions that may reflect more accurately the in vivo processes occurring in the gingival epithelium during the initiation of periodontal inflammation. In comparison to epithelial cell lines, HGECs are optimal, since the former have characteristics and receptors similar to fibroblasts and other cell types . The bacterial species incorporated in the in vitro 'subgingival' biofilm were chosen carefully based on the following criteria: 1) published reports that the species were frequently found and numerous in periodontal disease sites; and 2) that the species were cultivatable to permit enumeration and also measurable by fluorescent in situ hybridization (FISH) and if possible immunofluorescence (IF), in additional species-specific single-cell detection assays to ensure quality control. We thus compiled a list of nine microorganisms that, when incorporated in a biofilm, included widely accepted pathogenic microbiota [19–21]. Besides members of the gingival crevice plaque (e.g. Actinomyces naeslundii, Streptococcus oralis, Veillonella dispar) it comprises taxa detected most commonly in deep periodontal pockets and widely utilized in virulence experiments (e.g. Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythia) with planktonic cells.
We describe here the procedures to generate the complex 'subgingival' in vitro biofilms and the techniques used to challenge HGEC with such biofilms. We report on the kinetics and reproducibility of biofilm formation and on the effects of the biofilm on epithelial cells in terms of generating apoptosis, inducing pro-inflammatory primary and secondary cytokines, and triggering direct biofilm-mediated cytokine degradation.
Characterization of biofilm composition
Cell accumulation in the biofilm was fastest during the initial presence of the inoculum suspension (up to 16.5 h). Thereafter, the total cell number (TCC) as well as the cell numbers of the individual species continued to increase by approximately two log steps until the experiments were stopped at 64.5 h of biofilm formation. Culture and FISH analyses yielded very similar data for A. naeslundii, S. oralis, and V. dispar. The other more fastidious taxa were detected in somewhat higher numbers by FISH and IF (only four species studied by IF). Cell viability in 64.5 h biofilms was estimated microscopically by the in-/exclusion of fluorescent dyes and reached consistently 85%.
Composition of biofilms generated under different nutritional conditions.
Number of bacteria (± SD) present in biofilm per disc (cfu, ×106)
16.5 - 64.5 h
The in vitro'subgingival' biofilm induces apoptosis in HGEC
Biofilm-challenged HGEC elicit a cytokine response that is reduced over time
Cytokine degradation in biofilm challenged HGEC cultures.
We demonstrated that biofilms mimicking subgingival plaque can be established reproducibly in vitro. When exposed in co-culture to primary human epithelial cells, they induce cell apopotosis and production of pro-inflammatory primary and secondary cytokines. We further showed that the cytokines produced are immediately attacked by the biofilm. Thus, this co-culture model opposing a multi-species 'subgingival' biofilm to human oral epithelial cells mirrors two key aspects of the interactions taking place at the dental plaque:periodontal tissue interphase, namely the triggering of a strong pro-inflammatory host cell response and the simultaneous microbial subversion of host defense mechanisms. Our strategy to construct in vitro 'subgingival' biofilms makes use of the well-characterized 'supragingival' Zürich biofilm model [22, 23] made up of six species, which in vivo colonize preferentially at the tooth surface and at the gingival margin. By eliminating Streptococcus mutans/sobinus and Candida albicans, and addingthe putative periodontal pathogens C. rectus, P. gingivalis, P. intermedia, and T. forsythia, we assembled a consortium of microorganisms that much more mirrors subgingival plaque. Streptococcus intermedius completes the biofilm consortium, being a subgingival species also known for its association with dental implant infections, pyogenic infections, endocarditis, and various types of abscesses [24–26]. A second strategic aim was to move our in vitro 'subgingival' biofilms from strictly anaerobic to aerobic atmospheric conditions that match those used to propagate mammalian cells. If successful, this would be a major advance towards combining two in vitro model systems that basically seem to exclude each other. Our data show that biofilm adaptation to 5% O2 is feasible. They further show that the colonization reproducibility is not yet completely satisfactory as far as the most fastidious and most oxygen- sensitive species P. gingivalis, and T. forsythia are concerned (Fig. 1 and Table 1). This indicates that oxygen consumption by the microbial consortium - creating a low reduction potential - can be somewhat variable among parallel biofilms. Preliminary evidence suggests that later exposure of biofilms to oxygen (e.g. at 44.5 h) does not improve the growth of the subgingival anaerobes (with the possible exception of T. forsythia) and does not significantly reduce their viability either. The duration of the exposure to aerobic conditions had remarkably little effect on the ratios between the bacteria within the community (data not shown).
We used FISH, and in part indirect IF, in addition to quantitative culture for monitoring biofilm composition. Our data demonstrate the importance of using one or two complementary techniques, as any single technique may fail under particular circumstances. Examples in this study are the consistently reliable enumeration of F. nucleatum subsp. vincentii by FISH but not by culture due to difficulties in optimizing the F. nucleatum culture medium (a strain-specific phenomenon). CLSM of biofilms stained simultaneously for multiple bacterial species by multiplex FISH revealed a remarkable biofilm thickness of approximately 50 μm and provided preliminary evidence for microcolony formation by several biofilm organisms which is reminiscent of microcolonies found characteristically in subgingival plaques from deep progressed periodontal pockets. Primary HGEC challenged with such 'subgingival' biofilms were able to induce a cytokine response after 4 h of challenge (Fig. 4A &4B) and although this is not strictly comparable because we did not perform comprehensive side by side comparisons, the cytokine response was higher than the previously reported cytokine response elicited by single planktonic bacterial species [27, 28]. However, when the exposure time was prolonged to 24 h, the level of all cytokines had diminished significantly. We tested the hypothesis that the cytokine levels are reduced due to extracellular biofilm-mediated degradation. In fact, IL-6, and IL-8 degradation began immediately and progressively increased to reach approximately 25% after 4 h of exposure, but only in the presence of intact biofilm. This suggests that the presence of biofilm bacteria is necessary for IL-6 and IL-8 degradation, while IL-1β was found to be more susceptible to degradation by a soluble component in the biofilm culture medium. Biofilm-induced cytokine degradation could be, at least in part, due to the gingipain activity of P. gingivalis or a protease of T. forsythia with similar trypsin-like activity. Previous studies have shown that P. gingivalis can induce cytokine degradation [28–30] that is mainly lysine-gingipain-dependent. The lower rate of the biofilm-induced cytokine degradation observed in the present study compared to that induced by P. gingivalis monocultures  is possibly dose-related. Plaque mediated cytokine degradation is a potential mechanism to explain the reduced levels of pro-inflammatory cytokines (IL-6) and chemokines (IL-8) found in the GCF of patients with periodontitis [31–35], as well as the GCF from sites with active periodontal disease or unresolved defects following treatment [33, 36]. In addition to cytokine production, primary HGEC challenged in vitro with a 'subgingival' biofilm exhibited apoptosis as evidenced by DNA fragmentation, the hallmark of apoptosis. This is a potential mechanism to explain the apoptosis that is observed in the gingiva at sites of chronic bacteria-induced inflammation [37, 38], particularly among the superficial cells of the junctional epithelium  and the fibroblasts and leucocytes of the connective tissue [37, 38]. The high proportions of HGEC undergoing apoptosis in the described co-culture system, as well as the short exposure time that is necessary for the initiation of the apoptotic process, suggest that the in vitro 'subgingival' biofilm is a highly pathogenic entity, and possibly more pathogenic than single bacterial strains.
Our approach allowed us to directy link primary human gingival epithelial cells, being an integral part of the oral innate immune system, to an artificial, in vitro propagated 'subgingival' biofilm, and elicit various cell responses ranging from cytokine production to apoptosis. Our data indicate that, compared to responses triggered by planktonic individual species, the bacteria organized in an in vitro 'subgingival' biofilm express even more damaging virulence factors neutralizing the host cells' pro-inflammatory defense. As neither the culturing of host defense cells nor the assembly of artificial biofilms is restricted to oral tissues and bacteria, the same strategy of challenging cultured host cells with in vitro propagated bacterial biofilms may be of general interest and could be applied to study other elusive chronic inflammatory diseases.
In vitro biofilm generation
Technically, the 10-species biofilms used in this study are an advancement of the six-species model described previously [23, 39]. The following 10 strains were used: C. rectus OMZ 697, F. nucleatum subsp. vincentii KP-F2 (OMZ 596), P. gingivalis ATCC 33277T (OMZ 925), P. intermedia ATCC 25611T (OMZ 278), T. forsythia OMZ 1047, T. lecithinolyticum ATCC 700332T (OMZ 684), V. dispar ATCC 17748T (OMZ 493), A. naeslundii OMZ 745, S. intermedius ATCC 27335 (OMZ 512), and S. oralis SK 248 (OMZ 607). Biofilms were grown in 24-well polystyrene cell culture plates on sintered pellicle-coated HA discs (10.6 mm Ø) . To initiate biofilm formation discs were covered for the first 16.5 h with 1.6 ml of growth medium consisting of 60% saliva, 10% human serum (pool from three donors), 30% mFUM (modified fluid universal medium) [41, 42] and 200 μl of a bacterial cell suspension prepared from equal volumes and densities of each strain. After 16.5 h of anaerobic incubation at 37°C, the inoculum suspension was removed by "dip-washing"  the discs, which then were transferred into wells with fresh medium (60% saliva, 10% human serum, 30% mFUM) and incubated in an oxygen-containing atmosphere (90% N2, 5% CO2, 5% O2) for further 48 h. During this time-period discs were dip-washed after 20.5, 24.5, 40.5, 44.5 and 48.5 h and given fresh medium after 40.5 h. After 64.5 h of incubation, the discs were vigorously vortexed for 1 min in 0.9% NaCl to harvest the biofilms or intact biofilm-discs were frozen at -80°C for further use. This cultivation procedure (which corresponds to the culture conditions c/d in Table 1) was selected for use with all biofilm:HGEC co-culture experiments described herein after broad evaluation of other nutritional conditions. Options tested included richer conditions during the first 16.5 h (35% saliva and 35% human serum along with 30% mFUM) and several variations of the saliva, serum and mFUM concentration during the period from 16.5 to 64.5 h (Table 1). Further pre-testing to evaluate the effect of biofilm exposure to an oxygen-containing atmosphere and to the co-incubation with HGECusing KSFM were also investigated; although variations were observed, the number of anaerobic bacteria that survived after exposure to an aerobic environment was comparable to the pre-exposure levels (data not shown).
Analysis of biofilm composition
Suspensions of harvested bacteria were evaluated for cell viability using the LIVE/DEAD BacLight Bacterial Viability assay (Molecular Probes) as described .
Serial dilutions of suspended biofilm bacteria were prepared in 0.9% NaCl and 50 μl aliquots were plated on Columbia blood agar supplemented with 5% whole human blood (to estimate total CFU, A. naeslundii, C. rectus, S. intermedius, V. dispar) and phosphomycin (P. gingivalis, P. intermedia), on mitis salivarius agar (S. oralis), on fastidious anaerobe agar with erythromycin, vancomycin, and norfloxacin (F. nucleatum) , and on modified OMIZ-W68 agar  supplemented with lactose, caseinoglycomacropeptide, N-acetylmuramic acid, and N-acetylglucosamine to detect T. forsythia. With the exception of mitis-salivarius-agar plates (10% CO2) plates were incubated anaerobically at 37°C for 72 h. Species identification was achieved by observation of colony morphology in conjunction with microscopic and FISH examination of cells from selected colonies. Data were scored for each species as CFU per biofilm. T. lecithiolyticum was estimated by dark field microscopy and FISH.
FISH and IF
16S rRNA targeted DNA probe sequences, target sites and target taxa
Sequence (5' to 3')b
All biofilm members
CLSM and TEM analysis of biofilm structure
For CLSM intact biofilms were prepared first for multiplex FISH . Lysozyme treatment (1 min) was done only if the ensuing FISH included staining Gram-positive biofilm species. Following pre-hybridization (15 min, 46°C), the FISH procedure was executed two to three times per biofilm, always starting with the probe(s) requiring the highest formamide concentration . After the last FISH cycle excess saline was gently aspirated from the discs without touching the biofilms. They were embedded upside-down in 20 μl of Mowiol  and stored at room temperature in the dark for at least 6 h prior to microscopic examination. Stained biofilms were examined by CLSM at randomly selected positions  using a 100 × (numeric aperture 1.4) oil immersion objective, and filters set to 500-540 nm for detection of 6-carboxyfluorescein (FAM), 540-580 nm for Cy3, 590-630 nm for 5-carboxy-X-rhodamine (ROX) and 640-700 nm for Cy5. Image acquisition was done in 8-line average mode and the data were processed as described . To perform TEM biofilms were harvested at 64.5 h, fixed for 1 h in 2.5% glutaraldehyde, washed, and treated for 2 h with 1% osmium tetraoxide, all in cacodylate buffer, pH 7.4. Dehydration was done in a graded series of ethanol and then propyleneoxide before embedding with Epon in flat polystyrene wells. The hardened, embedded biofilms were cut into wedge-shaped pieces and treated with 10% EDTA for 3 days thus removing the HA. Ultra-thin sections were contrasted with saturated, acidified uranyl acetate and lead citrate for 3 min each. Sections were viewed on a Philips EM400T transmission electron microscope at 60 kV.
Gingival cell isolation and culture
Gingival tissue biopsies were obtained with informed consent from periodontally healthy patients undergoing crown-lengthening procedures at the University of Louisville School of Dentistry, Graduate Periodontics Clinic, according to an IRB approval. The gingiva was treated with 0.025% trypsin and 0.01% EDTA overnight at 4°C and HGEC were isolated as previously described . The authenticity of the gingival epithelial cells was confirmed by immunohistochemistry with mAb against human pankeratin (Dako) and histologically by cell morphology. The HGEC were seeded in 60-mm plastic tissue culture plates coated with type-I collagen (BD Biocoat) and incubated in 5% CO2 at 37°C using KSFM medium (Invitrogen) containing 10 μg ml-1 of insulin, 5 μg ml-1 of transferrin, 10 μM of 2-mercaptoethanol, 10 μM of 2-aminoethanol, 10 mM of sodium selenite, 50 μg ml-1 of bovine pituitary extract, 100 units ml-1 of penicillin/streptomycin and 50 ng ml-1 of fungizone (complete medium). When the cells reached sub-confluence, they were harvested and sub-cultured as described .
HGEC cultures at the fourth passage were harvested and seeded at a density of 0.5 × 105 cells per well in a 6-well culture plate coated with type-I collagen, and maintained in 2 ml of complete medium. The HGEC used in this study was chosen on the basis of it having a 'median' responsiveness, sufficient quantity of cells for testing and as our previous study showed consistent immunological trends among different cultures . Biofilms on HA discs were defrosted and carefully placed for 24 h ("revived") in fresh biofilm-medium (60% saliva, 10% human serum, 30% mFUM) or plain KSFM (for cytokine degradation experiments; as explained later) in an oxygen-containing atmosphere (90% N2, 5% CO2, 5% O2). When the HGEC reached confluence (approximately 106 cells per well), the HGEC were washed twice with fresh medium and then challenged for 4 or 24 h in antibiotic-free medium at 37°C in 5% CO2 with one biofilm carrying HA disc per well that had just been dipped three times in sterile normal saline solution. The co-culture set-up is illustrated in Fig. 3A. Discs were placed on the ring support (tip of a sterile plastic inoculation loop; Copan) with the biofilm towards the HGEC layer. A one millimeter distance between the biofilm and the HGEC was maintained to allow fluid flow . Neither the ring nor the HA disc triggered any of the HGEC responses assayed in this study. The effect of freezing, thawing and reviving of biofilms has been carefully assessed (data not shown). Results showed only minor differences in CFU/disc between fresh biofilms and biofilms that had been frozen, shipped, thawed and revived by incubating anaerobically in biofilm medium for 24 h (data not shown).
Cytokine production and degradation assay
IL-1β, IL-6 and IL-8 were measured by ELISA using the OptEIA kit (BD Biosciences) according to the manufacturer's instructions. The absorbance was read at 450 nm. P. gingivalis strains at low passage were grown anaerobically in GAM media (Nissui Pharmaceutical) for 2 days. After cultivation, the bacteria were harvested by centrifugation, washed in PBS (pH 7.4) and then heat-inactivated for 1 h at 60°C. Culture supernatants produced after a 24 h incubation of HGEC with heat-inactivated planktonic P. gingivalis (MOI:100) were incubated at 37°C with: (i) biofilm attached to HA discs (Biofilm), (ii) supernatant from the biofilm culture (64.5 h) in the specific mFUM media (Supernatant), (iii) supernatant from a 24 h "revival" incubation of biofilm discs in plain KSFM either filtered or unfiltered (media filtered and media unfiltered). The reaction was stopped at 1 min, 30 min, 1 h, 2 h and 4 h by placing the samples at -80°C until ELISA. All data are expressed as the mean ± SD of three experiments done in triplicate. Statistical analyses were performed by one-way analysis of variance (ANOVA) using the InStat program (GraphPad, San Diego, CA) with Bonferroni correction. Statistical differences were considered significant at the p < 0.05 level.
Direct TUNEL (Terminal deoxynucleotidyl Transferase Fluorescein-dUTP Nick End Labeling) assay was performed using a commercially available kit (Cat No 11-684795001, Roche Applied Science). Untreated cells were used as a negative control and cells treated with DNase 1000 U/ml were used as a positive control. The assay was performed according to the manufacturer's instructions. Briefly, the HGEC were washed three times with PBS, fixed with 4% paraformaldehyde(pH 7.4) for 30 min at room temperature, washed twice, and then permeabilized with 0.1% Triton X (Sigma-Aldrich) for 3 minutes on ice. After two washes, the cells were incubated with the TUNEL reaction mixture for 60 min at 37°C and then washed three times before analysis by CLSM (FluoView 500, Olympus). The percentage of apoptotic cells was determined by counting TUNEL-positive cells, cells exhibiting pyknosis and blebbing, and all cells present in four representative fields of vision (× 600 magnification) from each of two cultures with which TUNEL assays were performed.
confocal laser scanning microscopy
fluorescent in situ hybridization
human gingival epithelial cells
modified fluid universal medium
multiplicity of infection
total cell number
transmission electron microscopy.
We thank Dr. Chris Wyss for the preparation of T. forsythia cultures and helpful discussions. We thank Helga Lüthi-Schaller for excellent assistance with FISH and IF, and Steve Reese for performing the TEM. This work was in part supported by the University of Zürich and United States Public Health Service, National Institutes of Health, NIDCR grant DE017384 to DFK.
- Costerton JW, Geesey GG, Cheng KJ: How bacteria stick. Sci Am. 1978, 238 (1): 86-95.PubMedView ArticleGoogle Scholar
- Costerton JW, Stewart PS, Greenberg EP: Bacterial biofilms: a common cause of persistent infections. Science. 1999, 284 (5418): 1318-1322. 10.1126/science.284.5418.1318.PubMedView ArticleGoogle Scholar
- Kinane DF, Galicia JC, Gorr SU, Stathopoulou PG, Benakanakere M: P. gingivalis interactions with epithelial cells. Front Biosci. 2008, 13: 966-984. 10.2741/2736.PubMedView ArticleGoogle Scholar
- Kolenbrander PE: Oral microbial communities: biofilms, interactions, and genetic systems. Annu Rev Microbiol. 2000, 54: 413-437. 10.1146/annurev.micro.54.1.413.PubMedView ArticleGoogle Scholar
- Marsh PD: Are dental diseases examples of ecological catastrophes?. Microbiology. 2003, 149 (Pt 2): 279-294. 10.1099/mic.0.26082-0.PubMedView ArticleGoogle Scholar
- Rosan B, Lamont RJ: Dental plaque formation. Microbes Infect. 2000, 2 (13): 1599-1607. 10.1016/S1286-4579(00)01316-2.PubMedView ArticleGoogle Scholar
- Christersson LA, Zambon JJ, Genco RJ: Dental bacterial plaques. Nature and role in periodontal disease. J Clin Periodontol. 1991, 18 (6): 441-446. 10.1111/j.1600-051X.1991.tb02314.x.PubMedView ArticleGoogle Scholar
- O'Toole G, Kaplan HB, Kolter R: Biofilm formation as microbial development. Annu Rev Microbiol. 2000, 54: 49-79. 10.1146/annurev.micro.54.1.49.PubMedView ArticleGoogle Scholar
- Davies D: Understanding biofilm resistance to antibacterial agents. Nat Rev Drug Discov. 2003, 2 (2): 114-122. 10.1038/nrd1008.PubMedView ArticleGoogle Scholar
- Galli J, Ardito F, Calo L, Mancinelli L, Imperiali M, Parrilla C, Picciotti PM, Fadda G: Recurrent upper airway infections and bacterial biofilms. J Laryngol Otol. 2007, 121 (4): 341-344. 10.1017/S0022215106003896.PubMedView ArticleGoogle Scholar
- Parsek MR, Singh PK: Bacterial biofilms: an emerging link to disease pathogenesis. Annu Rev Microbiol. 2003, 57: 677-701. 10.1146/annurev.micro.57.030502.090720.PubMedView ArticleGoogle Scholar
- Ramirez P, Ferrer M, Torres A: Prevention measures for ventilator-associated pneumonia: a new focus on the endotracheal tube. Curr Opin Infect Dis. 2007, 20 (2): 190-197. 10.1097/QCO.0b013e328014daac.PubMedView ArticleGoogle Scholar
- Stickler DJ: Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol. 2008, 5 (11): 598-608. 10.1038/ncpuro1231.PubMedView ArticleGoogle Scholar
- Williams GJ, Stickler DJ: Effect of triclosan on the formation of crystalline biofilms by mixed communities of urinary tract pathogens on urinary catheters. J Med Microbiol. 2008, 57 (Pt 9): 1135-1140. 10.1099/jmm.0.2008/002295-0.PubMedView ArticleGoogle Scholar
- Oscarsson J, Karched M, Thay B, Chen C, Asikainen S: Proinflammatory effect in whole blood by free soluble bacterial components released from planktonic and biofilm cells. BMC Microbiol. 2008, 8: 206-10.1186/1471-2180-8-206.PubMed CentralPubMedView ArticleGoogle Scholar
- Daep CA, Lamont RJ, Demuth DR: Interaction of Porphyromonas gingivalis with oral streptococci requires a motif that resembles the eukaryotic nuclear receptor box protein-protein interaction domain. Infect Immun. 2008, 76 (7): 3273-3280. 10.1128/IAI.00366-08.PubMed CentralPubMedView ArticleGoogle Scholar
- Ramsey MM, Whiteley M: Polymicrobial interactions stimulate resistance to host innate immunity through metabolite perception. Proc Natl Acad Sci USA. 2009, 106 (5): 1578-1583. 10.1073/pnas.0809533106.PubMed CentralPubMedView ArticleGoogle Scholar
- Kinane DF, Shiba H, Stathopoulou PG, Zhao H, Lappin DF, Singh A, Eskan MA, Beckers S, Waigel S, Alpert B, et al: Gingival epithelial cells heterozygous for Toll-like receptor 4 polymorphisms Asp299Gly and Thr399ile are hypo-responsive to Porphyromonas gingivalis. Genes Immun. 2006, 7 (3): 190-200. 10.1038/sj.gene.6364282.PubMedView ArticleGoogle Scholar
- Moore WE, Moore LV: The bacteria of periodontal diseases. Periodontol 2000. 1994, 5: 66-77. 10.1111/j.1600-0757.1994.tb00019.x.PubMedView ArticleGoogle Scholar
- Socransky SS, Haffajee AD: Periodontal microbial ecology. Periodontol 2000. 2005, 38: 135-187. 10.1111/j.1600-0757.2005.00107.x.PubMedView ArticleGoogle Scholar
- Tanner A, Maiden MF, Macuch PJ, Murray LL, Kent RL: Microbiota of health, gingivitis, and initial periodontitis. J Clin Periodontol. 1998, 25 (2): 85-98. 10.1111/j.1600-051X.1998.tb02414.x.PubMedView ArticleGoogle Scholar
- Guggenheim B, Guggenheim M, Gmur R, Giertsen E, Thurnheer T: Application of the Zurich biofilm model to problems of cariology. Caries Res. 2004, 38 (3): 212-222. 10.1159/000077757.PubMedView ArticleGoogle Scholar
- Shapiro S, Giertsen E, Guggenheim B: An in vitro oral biofilm model for comparing the efficacy of antimicrobial mouthrinses. Caries Res. 2002, 36 (2): 93-100. 10.1159/000057866.PubMedView ArticleGoogle Scholar
- Magnusson I, Walker CB: Refractory periodontitis or recurrence of disease. J Clin Periodontol. 1996, 23 (3 Pt 2): 289-292. 10.1111/j.1600-051X.1996.tb02091.x.PubMedView ArticleGoogle Scholar
- Tanner A, Maiden MF, Lee K, Shulman LB, Weber HP: Dental implant infections. Clin Infect Dis. 1997, 25 (Suppl 2): S213-217. 10.1086/516243.PubMedView ArticleGoogle Scholar
- Tran MP, Caldwell-McMillan M, Khalife W, Young VB: Streptococcus intermedius causing infective endocarditis and abscesses: a report of three cases and review of the literature. BMC Infect Dis. 2008, 8: 154-10.1186/1471-2334-8-154.PubMed CentralPubMedView ArticleGoogle Scholar
- Eskan MA, Benakanakere MR, Rose BG, Zhang P, Zhao J, Stathopoulou P, Fujioka D, Kinane DF: Interleukin-1beta modulates proinflammatory cytokine production in human epithelial cells. Infect Immun. 2008, 76 (5): 2080-2089. 10.1128/IAI.01428-07.PubMed CentralPubMedView ArticleGoogle Scholar
- Stathopoulou PG, Benakanakere MR, Galicia JC, Kinane DF: The host cytokine response to Porphyromonas gingivalis is modified by gingipains. Oral Microbiol Immunol. 2009, 24 (1): 11-17. 10.1111/j.1399-302X.2008.00467.x.PubMed CentralPubMedView ArticleGoogle Scholar
- Fletcher J, Reddi K, Poole S, Nair S, Henderson B, Tabona P, Wilson M: Interactions between periodontopathogenic bacteria and cytokines. J Periodontal Res. 1997, 32 (1 Pt 2): 200-205. 10.1111/j.1600-0765.1997.tb01406.x.PubMedView ArticleGoogle Scholar
- Steffen MJ, Holt SC, Ebersole JL: Porphyromonas gingivalis induction of mediator and cytokine secretion by human gingival fibroblasts. Oral Microbiol Immunol. 2000, 15 (3): 172-180. 10.1034/j.1399-302x.2000.150305.x.PubMedView ArticleGoogle Scholar
- Chung RM, Grbic JT, Lamster IB: Interleukin-8 and beta-glucuronidase in gingival crevicular fluid. J Clin Periodontol. 1997, 24 (3): 146-152. 10.1111/j.1600-051X.1997.tb00483.x.PubMedView ArticleGoogle Scholar
- Jin L, Soder B, Corbet EF: Interleukin-8 and granulocyte elastase in gingival crevicular fluid in relation to periodontopathogens in untreated adult periodontitis. J Periodontol. 2000, 71 (6): 929-939. 10.1902/jop.2000.71.6.929.PubMedView ArticleGoogle Scholar
- Mathur A, Michalowicz B, Castillo M, Aeppli D: Interleukin-1 alpha, interleukin-8 and interferon-alpha levels in gingival crevicular fluid. J Periodontal Res. 1996, 31 (7): 489-495. 10.1111/j.1600-0765.1996.tb01414.x.PubMedView ArticleGoogle Scholar
- Ozmeric N, Bal B, Balos K, Berker E, Bulut S: The correlation of gingival crevicular fluid interleukin-8 levels and periodontal status in localized juvenile periodontitis. J Periodontol. 1998, 69 (11): 1299-1304.PubMedView ArticleGoogle Scholar
- Reinhardt RA, Masada MP, Payne JB, Allison AC, DuBois LM: Gingival fluid IL-1 beta and IL-6 levels in menopause. J Clin Periodontol. 1994, 21 (1): 22-25. 10.1111/j.1600-051X.1994.tb00271.x.PubMedView ArticleGoogle Scholar
- Guillot JL, Pollock SM, Johnson RB: Gingival interleukin-6 concentration following phase I therapy. J Periodontol. 1995, 66 (8): 667-672.PubMedView ArticleGoogle Scholar
- Koulouri O, Lappin DF, Radvar M, Kinane DF: Cell division, synthetic capacity and apoptosis in periodontal lesions analysed by in situ hybridisation and immunohistochemistry. J Clin Periodontol. 1999, 26 (8): 552-559. 10.1034/j.1600-051X.1999.260810.x.PubMedView ArticleGoogle Scholar
- Tonetti MS, Cortellini D, Lang NP: In situ detection of apoptosis at sites of chronic bacterially induced inflammation in human gingiva. Infect Immun. 1998, 66 (11): 5190-5195.PubMed CentralPubMedGoogle Scholar
- Thurnheer T, Gmur R, Shapiro S, Guggenheim B: Mass transport of macromolecules within an in vitro model of supragingival plaque. Appl Environ Microbiol. 2003, 69 (3): 1702-1709. 10.1128/AEM.69.3.1702-1709.2003.PubMed CentralPubMedView ArticleGoogle Scholar
- Gmur R, Giertsen E, Veen van der MH, de Josselin de Jong E, ten Cate JM, Guggenheim B: In vitro quantitative light-induced fluorescence to measure changes in enamel mineralization. Clin Oral Investig. 2006, 10 (3): 187-195. 10.1007/s00784-006-0058-z.PubMedView ArticleGoogle Scholar
- Gmur R, Guggenheim B: Antigenic heterogeneity of Bacteroides intermedius as recognized by monoclonal antibodies. Infect Immun. 1983, 42 (2): 459-470.PubMed CentralPubMedGoogle Scholar
- Guggenheim B, Giertsen E, Schupbach P, Shapiro S: Validation of an in vitro biofilm model of supragingival plaque. J Dent Res. 2001, 80 (1): 363-370. 10.1177/00220345010800011201.PubMedView ArticleGoogle Scholar
- Wyss C: Fatty acids synthesized by oral treponemes in chemically defined media. FEMS Microbiol Lett. 2007, 269 (1): 70-76. 10.1111/j.1574-6968.2006.00609.x.PubMedView ArticleGoogle Scholar
- Zuger J, Luthi-Schaller H, Gmur R: Uncultivated Tannerella BU045 and BU063 are slim segmented filamentous rods of high prevalence but low abundance in inflammatory disease-associated dental plaques. Microbiology. 2007, 153 (Pt 11): 3809-3816. 10.1099/mic.0.2007/010926-0.PubMedView ArticleGoogle Scholar
- Werner-Felmayer G, Guggenheim B, Gmur R: Production and characterization of monoclonal antibodies against Bacteroides forsythus and Wolinella recta. J Dent Res. 1988, 67 (3): 548-553.PubMedView ArticleGoogle Scholar
- Gmur R, Werner-Felmayer G, Guggenheim B: Production and characterization of monoclonal antibodies specific for Bacteroides gingivalis. Oral Microbiol Immunol. 1988, 3 (4): 181-186. 10.1111/j.1399-302X.1988.tb00007.x.PubMedView ArticleGoogle Scholar
- Thurnheer T, Gmur R, Guggenheim B: Multiplex FISH analysis of a six-species bacterial biofilm. J Microbiol Methods. 2004, 56 (1): 37-47. 10.1016/j.mimet.2003.09.003.PubMedView ArticleGoogle Scholar
- Thurnheer T, Ploeg van der JR, Giertsen E, Guggenheim B: Effects of Streptococcus mutans gtfC deficiency on mixed oral biofilms in vitro. Caries Res. 2006, 40 (2): 163-171. 10.1159/000091065.PubMedView ArticleGoogle Scholar
- Shiba H, Venkatesh SG, Gorr SU, Barbieri G, Kurihara H, Kinane DF: Parotid secretory protein is expressed and inducible in human gingival keratinocytes. J Periodontal Res. 2005, 40 (2): 153-157. 10.1111/j.1600-0765.2005.00781.x.PubMedView ArticleGoogle Scholar
- Feng L, Sun W, Xia Y, Tang WW, Chanmugam P, Soyoola E, Wilson CB, Hwang D: Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys. 1993, 307 (2): 361-368. 10.1006/abbi.1993.1601.PubMedView ArticleGoogle Scholar
- Goodson JM: Gingival crevice fluid flow. Periodontol 2000. 2003, 31: 43-54. 10.1034/j.1600-0757.2003.03104.x.PubMedView ArticleGoogle Scholar
- Amann RI, Ludwig W, Schleifer KH: Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol Rev. 1995, 59 (1): 143-169.PubMed CentralPubMedGoogle Scholar
- Kubota K, Ohashi A, Imachi H, Harada H: Improved in situ hybridization efficiency with locked-nucleic-acid-incorporated DNA probes. Appl Environ Microbiol. 2006, 72 (8): 5311-5317. 10.1128/AEM.03039-05.PubMed CentralPubMedView ArticleGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.